Diagnostics
Non-invasive liver fibrosis biomarkers revealed in hepatitis C hemophiliacs
Published in Hepatitis Weekly, August 21st, 2006
"Liver biopsy remains the gold standard for the evaluation of fibrosis despite its risks and limitations, especially in haemophilia patients. Recently, non-invasive biomarkers have been used to assess histological features. The most thoroughly evaluated biomarker is the FibroTest (FT) (AUROC 0.80 for fibrosis stages F2F3F4 vs. F0F1)."
Y. Maor and colleagues, Chaim Sheba Medical Center, wrote that the study was done, "to estimate liver fibrosis in haemophilia patients infected with HCV using non-invasive biomarkers...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2006-08-21)
More Articles from Hepatitis Weekly
- Hepatitis B Virus
Hepatitis antigen-negative foci originate separately from hepatocellular carcinomas - Hepatitis B Virus
Non-invasive models fail to predict histology in chronic hepatitis B - Hepatitis B Virus
Regulatory T cells influence hepatitis B disease progression - Hepatitis B Virus
Synthetic hepatitis B virus gene expressed and purified - Hepatitis C Virus
Specific populations of memory cells display distinct homing phenotypes - Adverse Drug Reaction
Toxicity of combination therapy detected in cirrhotic patients with hepatitis C - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
